Published in Scand J Gastroenterol on March 01, 1996
Helicobacter pylori infection in Ontario: prevalence and risk factors. Can J Gastroenterol (2007) 1.08
Seroconversion and seroreversion in IgG antibodies to Helicobacter pylori: a serology based prospective cohort study. J Epidemiol Community Health (2000) 1.02
Helicobacter pylori heat shock protein A: serologic responses and genetic diversity. Clin Diagn Lab Immunol (1999) 0.91
Helicobacter pylori antibody patterns in Germany: a cross-sectional population study. Gut Pathog (2014) 0.83
Serum Cytokine Signature That Discriminates Helicobacter pylori Positive and Negative Juvenile Gastroduodenitis. Front Microbiol (2016) 0.75
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med (1987) 13.50
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation (1992) 4.96
The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med (1994) 4.41
Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet (1997) 4.19
Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology (1991) 3.38
Pepsinogens: genetic polymorphism in man. Science (1970) 3.07
Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology (1982) 3.05
Ultrasound screening and perinatal mortality: controlled trial of systematic one-stage screening in pregnancy. The Helsinki Ultrasound Trial. Lancet (1990) 3.03
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA (1988) 2.89
Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Benedectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol (1977) 2.65
Genetic heterogeneity of hyperpepsinogenemic I and normopepsinogenemic I duodenal ulcer disease. Ann Intern Med (1979) 2.61
Gastric acidity in older adults. JAMA (1997) 2.34
Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet (1986) 2.34
Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr (1995) 2.25
Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Lancet (1986) 2.21
Prevalence of gastritis in a rural population. Bioptic study of subjects selected at random. Scand J Gastroenterol (1968) 2.09
Stable antibody-producing murine hybridomas. Science (1983) 2.06
Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J Bacteriol (1992) 1.98
Electrophoretic heterogeneity and relationships of pepsinogens in human urine, serum, and gastric mucosa. Gastroenterology (1970) 1.92
Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother (1992) 1.92
Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer (1985) 1.89
Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence. Gastroenterology (1973) 1.82
Measles history and atopic diseases: a population-based cross-sectional study. JAMA (2000) 1.81
Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol (1992) 1.76
Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland) Cancer Causes Control (2000) 1.75
Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care (1992) 1.75
Atrophic gastritis and its sequelae. Results of 19-23 years' follow-up examinations. Scand J Gastroenterol (1974) 1.73
Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob Agents Chemother (1991) 1.72
Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology (1982) 1.72
Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun (1992) 1.71
Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer. Gastroenterology (1975) 1.68
Coffee and myocardial infarction. N Engl J Med (1973) 1.66
An acid extract as a common antigen in Campylobacter coli and Campylobacter jejuni strains. J Clin Microbiol (1983) 1.65
Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence. Gastroenterology (1971) 1.64
Serology of Campylobacter fetus ss. jejuni )"related" campylobacters). Demonstration of strain-specific and interstrain-related antigens by immunoelectrophoresis and co-agglutination. Acta Pathol Microbiol Scand B (1980) 1.64
Low-level air pollution and upper respiratory infections in children. Am J Public Health (1991) 1.63
Risk factors in dental erosion. J Dent Res (1991) 1.62
Helicobacter pylori induces lymphocyte activation in peripheral blood cultures. Clin Exp Immunol (1990) 1.62
Duodenal-ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal dominant disorder. N Engl J Med (1979) 1.61
Hyperostosis of the spine in an adult population. Its relation to hyperglycaemia and obesity. Ann Rheum Dis (1971) 1.61
Long-term follow-up of duodenal ulcer patients. J Clin Gastroenterol (1983) 1.59
Studies of patients with atrophic gastritis: a 10-15-year follow-up. Scand J Gastroenterol (1966) 1.57
Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers. Lancet (1985) 1.55
Celiac disease and multiple jejunal diverticulosis. Am J Dig Dis (1967) 1.55
Cardiovascular birth defects and antenatal exposure to female sex hormones. N Engl J Med (1977) 1.53
Maternal hyperthermia during pregnancy and cardiovascular malformations in the offspring. Eur J Epidemiol (1991) 1.52
Reserpine use in relation to breast cancer. Lancet (1974) 1.51
Anticonvulsants and parental epilepsy in the development of birth defects. Lancet (1976) 1.51
Population studies of pepsinogen polymorphism. Am J Hum Genet (1973) 1.50
Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect (1997) 1.49
Morphological, functional and immunological state of the gastric mucosa in gastric carcinoma families. Comparison with a computer-matched family sample. Scand J Gastroenterol (1979) 1.49
Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol (1996) 1.48
Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa; its association with gastric carcinoma. Acta Pathol Microbiol Scand A (1980) 1.47
Cimetidine versus intensive antacid therapy for duodenal ulcer: a multicenter trial. Gastroenterology (1978) 1.47
Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. J Bacteriol (1991) 1.46
Validity of diagnoses of major coronary events in national registers of hospital diagnoses and deaths in Finland. Eur J Epidemiol (1997) 1.46
Validation of stroke diagnosis in the National Hospital Discharge Register and the Register of Causes of Death in Finland. Eur J Epidemiol (1999) 1.45
Pachydermoperiostosis, hypertrophic gastropathy, and peptic ulcer. Gastroenterology (1983) 1.44
Risk factors for coarctation of the aorta. Teratology (1993) 1.44
Prognosis of patients with lung cancer found in a single chest radiograph screening. Chest (1998) 1.44
Cost-effectiveness of one-stage ultrasound screening in pregnancy: a report from the Helsinki ultrasound trial. Ultrasound Obstet Gynecol (1996) 1.44
Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains. Gut (2002) 1.43
Prolonged campylobacter gastroenteritis in a patient with hypogammaglobulinaemia. Acta Med Scand (1983) 1.41
Campylobacter enteritis in 188 hospitalized patients. Arch Intern Med (1983) 1.41
Radioimmunoassay of group I pepsinogens in serum. Gastroenterology (1974) 1.40
Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol Scand (1998) 1.39
Predisposition to spina bifida: Search for a relation to maternal gastric acid secretion. J Med Genet (1977) 1.38
Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample. Cancer (1983) 1.36
Slow moving protease and the seven pepsinogens. Electrophoretic demontration of the existence of eight proteolytic fractions in human gastric mucosa. Gastroenterology (1969) 1.35
Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol (1973) 1.34
The epidemiology of hyperostosis of the spine together with its symptoms and related mortality in a general population. Scand J Rheumatol (1975) 1.34
Dietary antioxidants and the risk of lung cancer. Am J Epidemiol (1991) 1.32
Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol (2000) 1.32
Mumps and rubella eliminated from Finland. JAMA (2000) 1.32
Serology of Campylobacter fetus ss. jejuni. 2 Serotyping of live bacteria by slide, latex and co-agglutination tests. Acta Pathol Microbiol Immunol Scand B (1982) 1.30
Efficacy of gemfibrozil in dyslipidaemic subjects with suspected heart disease. An ancillary study in the Helsinki Heart Study frame population. Ann Med (1993) 1.29
Reactive arthritis after campylobacter jejuni enteritis in patients with HLA-B27. Lancet (1980) 1.29
Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol Suppl (1991) 1.28
Arthritis associated with Campylobacter jejuni enteritis. Scand J Rheumatol (1981) 1.27
Aspirin and congenital malformations. Lancet (1976) 1.26
Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur J Immunol (1992) 1.25
Pepsinogens, pepsins, and pepsin inhibitors. Gastroenterology (1971) 1.25
Selective binding of sucralfate to gastric ulcer in man. Dig Dis Sci (1981) 1.24
Family studies of hypergastrinemic, hyperpepsinogenemic I duodenal ulcer. Ann Intern Med (1981) 1.21
Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med (1998) 1.21
Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro. Arthritis Rheum (1980) 1.21
Morphologic characteristics of jejunal biopsy in celiac disease and tropical sprue. Am J Pathol (1965) 1.20
The Helsinki Heart Study: an 8.5-year safety and mortality follow-up. J Intern Med (1994) 1.20
Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group. Scand J Gastroenterol (2000) 1.19
Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol (1996) 1.18
Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology (1986) 1.16
Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease. J Clin Pathol (1996) 1.16
Campylobacter etiology in human gastroenteritis demonstrated by antibodies to acid extract antigen. J Clin Microbiol (1987) 1.16
Effect of erythromycin on the fecal excretion of Campylobacter fetus subspecies jejuni. J Infect Dis (1982) 1.16
Tropical sprue in Haiti. Ann Intern Med (1966) 1.16